1. Home
  2. DXCM vs RJF Comparison

DXCM vs RJF Comparison

Compare DXCM & RJF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DXCM
  • RJF
  • Stock Information
  • Founded
  • DXCM 1999
  • RJF 1962
  • Country
  • DXCM United States
  • RJF United States
  • Employees
  • DXCM N/A
  • RJF N/A
  • Industry
  • DXCM Medical/Dental Instruments
  • RJF Investment Bankers/Brokers/Service
  • Sector
  • DXCM Health Care
  • RJF Finance
  • Exchange
  • DXCM Nasdaq
  • RJF Nasdaq
  • Market Cap
  • DXCM 35.7B
  • RJF 32.8B
  • IPO Year
  • DXCM 2005
  • RJF N/A
  • Fundamental
  • Price
  • DXCM $88.78
  • RJF $151.53
  • Analyst Decision
  • DXCM Strong Buy
  • RJF Buy
  • Analyst Count
  • DXCM 17
  • RJF 12
  • Target Price
  • DXCM $99.06
  • RJF $166.09
  • AVG Volume (30 Days)
  • DXCM 3.4M
  • RJF 1.5M
  • Earning Date
  • DXCM 02-13-2025
  • RJF 01-29-2025
  • Dividend Yield
  • DXCM N/A
  • RJF 1.32%
  • EPS Growth
  • DXCM 9.35
  • RJF 28.28
  • EPS
  • DXCM 1.42
  • RJF 10.24
  • Revenue
  • DXCM $4,033,000,000.00
  • RJF $13,239,000,000.00
  • Revenue This Year
  • DXCM $16.44
  • RJF $12.39
  • Revenue Next Year
  • DXCM $15.78
  • RJF $7.05
  • P/E Ratio
  • DXCM $62.34
  • RJF $14.80
  • Revenue Growth
  • DXCM 11.34
  • RJF 12.75
  • 52 Week Low
  • DXCM $62.34
  • RJF $104.24
  • 52 Week High
  • DXCM $142.00
  • RJF $174.32
  • Technical
  • Relative Strength Index (RSI)
  • DXCM 57.72
  • RJF 29.75
  • Support Level
  • DXCM $83.20
  • RJF $158.73
  • Resistance Level
  • DXCM $93.25
  • RJF $162.04
  • Average True Range (ATR)
  • DXCM 2.20
  • RJF 3.71
  • MACD
  • DXCM -0.09
  • RJF -1.69
  • Stochastic Oscillator
  • DXCM 55.52
  • RJF 6.27

About DXCM DexCom Inc.

Dexcom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.

About RJF Raymond James Financial Inc.

Raymond James Financial is a financial holding company whose major operations include wealth management, investment banking, asset management, and commercial banking. The company supports more than 8,000 employee and independent contractor financial advisors across the United States, Canada, and the United Kingdom with over $1.5 trillion of assets under administration as of September 2024. Approximately 90% of the company's revenue is from the US and 70% is from the company's wealth-management segment.

Share on Social Networks: